Alpha Cognition (ACOG) Amortization - Intangibles (2024 - 2026)
Alpha Cognition (ACOG) posted quarterly Amortization - Intangibles of $5386.0 for Q4 2025, down 72.74% year-over-year from $19760.0 in Q4 2024, and little changed quarter-over-quarter from $5387.0 in Q3 2025.
Alpha Cognition (ACOG) Amortization - Intangibles (2024 - 2026) Analysis & Trends
Alpha Cognition's Amortization - Intangibles history runs 2 years deep, the most recent figure standing at $5386.0 for Q4 2025.
- In Q4 2025, Amortization - Intangibles fell 72.74% year-over-year to $5386.0; the TTM figure through Dec 2025 stood at $21546.0 (down 73.03% YoY), while the FY2025 annual figure was $21546.0, down 73.03% from the prior year.
- Amortization - Intangibles for Q4 2025 stood at $5386.0, roughly flat from $5387.0 in the prior quarter.
- The five-year high for Amortization - Intangibles was $20594.0 in Q1 2024, with the low at $5386.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alpha Cognition | 219.48 Mn | 178.04 Mn | 5.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 74,229.00 |
| Dec 31, 2025 | 5,386.00 |
| Sep 30, 2025 | 5,387.00 |
| Jun 30, 2025 | 5,386.00 |
| Mar 31, 2025 | 5,387.00 |
| Dec 31, 2024 | 19,760.00 |
| Sep 30, 2024 | 19,761.00 |
| Jun 30, 2024 | 19,760.00 |
| Mar 31, 2024 | 20,594.00 |